Evidence map›Paper›PMID 41471205›Full record

ArticlePathogens (Basel, Switzerland)2025

Implementation of Poliovirus Containment in Poliovirus Designated Facilities-United States, 2017-2024.

Christy Ottendorfer, Patrick Vander Kelen, Cecelia A Sanders, Emily Watson, Suganthi Suppiah, William Hoffman, Colby Sinclair, Abena Marfo, Lia Haynes Smith

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christy OttendorferCenters for Disease Control and Prevention, Office of Readiness and Response, U.S. National Authority for Containment of Poliovirus, Atlanta, GA 30329, USA.
Patrick Vander KelenCenters for Disease Control and Prevention, Office of Readiness and Response, U.S. National Authority for Containment of Poliovirus, Atlanta, GA 30329, USA.ORCID 0000-0001-9462-7733
Cecelia A SandersCenters for Disease Control and Prevention, Office of Readiness and Response, U.S. National Authority for Containment of Poliovirus, Atlanta, GA 30329, USA.ORCID 0000-0002-7395-7335
Emily WatsonCenters for Disease Control and Prevention, Office of Readiness and Response, U.S. National Authority for Containment of Poliovirus, Atlanta, GA 30329, USA.
Suganthi SuppiahCenters for Disease Control and Prevention, Office of Readiness and Response, U.S. National Authority for Containment of Poliovirus, Atlanta, GA 30329, USA.
William HoffmanApplied Science, Research & Technology, Inc., Smyrna, GA 30080, USA.ORCID 0009-0003-4062-3093
Colby SinclairCenters for Disease Control and Prevention, Office of Readiness and Response, U.S. National Authority for Containment of Poliovirus, Atlanta, GA 30329, USA.
Abena MarfoHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Lia Haynes SmithCenters for Disease Control and Prevention, Office of Readiness and Response, U.S. National Authority for Containment of Poliovirus, Atlanta, GA 30329, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the world approaches wild poliovirus eradication, effective containment measures are essential to minimize the risk of a facility-associated reintroduction into a polio-free community. Between 2017 and 2024, the United States established a national authority for containment (NAC) of poliovirus to maintain a national inventory of poliovirus materials and designate facilities to retain polioviruses. Countries with designated facilities are expected to maintain primary, secondary, and tertiary safeguards for facility containment certification. Primary safeguard requirements are assessed through audits following an ISO risk-based process. Standardized data collection and reporting tools were developed in Microsoft Access, and data were analyzed using SAS

Indexed as

Containment of BiohazardsInfection ControlPoliomyelitisPoliovirusDisease EradicationHumansUnited Statesbiorisk management systemISO 35001laboratory containmentpoliovirus

Identifiers

PMID41471205
PMCPMC12735635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.